EMEA-001495-PIP02-21

Key facts

Active substance
drospirenone
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0451/2021
PIP number
EMEA-001495-PIP02-21
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of endometriosis
Route(s) of administration
Oral use
Contact for public enquiries
Chemo Research, S.L.

Email: Barbara.Herranz@exeltis.com 
Tel: +34 917711500
 

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating